Explore the risks, research gaps, and long-term safety questions surrounding GLP-1 weight-loss drugs prescribed to children and adolescents.

Duke research finds teens retain metabolic flexibility in obesity, pointing to adolescence as a key window for earlier, more effective treatment.

In one study, the great majority of respondents found “weight” and “unhealthy weight” to be the least offensive terms.

How can activating a brain receptor involved in appetite and blocking it both lead to weight loss? Here are some answers.

A recent study examined the existence and relationship of two concepts, weight stigma and weight stigma by association.

A Yale study finds Ozempic may activate hunger neurons to sustain fat loss, reshaping how scientists understand GLP-1 weight-loss drugs.

New research finds GLP-1 medications are replacing bariatric surgery for many young people with obesity, while access disparities remain a concern.

Should children under 12 take GLP-1 weight-loss drugs? Learn the benefits, risks, expert opinions, and why doctors remain divided on early treatment.

New research links Chile’s front-of-package labels, marketing restrictions, and school food policies to lower childhood obesity rates and healthier outcomes.

New research suggests fathers influence childhood obesity risk before conception through their health, lifestyle habits, mental health, and family environment.

“Overweight” and “obesity” are shifty characters who refuse to stand still and have their pictures taken for the record.

New research suggests GLP-1 medications may help slow the progression of certain cancers and reduce mortality risk, though more studies are needed.

New research suggests childhood junk food may permanently rewire the brain, increasing overeating risk and impacting long-term health.

New research challenges the “adiposity rebound” theory, suggesting early childhood BMI increases may reflect healthy muscle growth, not fat gain.

Does marijuana cause users to “get the munchies” and consequently grow obese? It ain’t necessarily so. One study showed weight loss.

Childhood obesity in the U.S.: rising rates, health disparities, economic impact, and the importance of early prevention.

Some states are reconsidering Medicaid coverage for GLP-1 weight loss drugs amid rising costs. What does it mean for obesity treatment access?

New research suggests BMI increases in children may reflect muscle growth, not body fat, highlighting the importance of waist-to-height ratio.

Explore how genetics may influence the effectiveness of GLP-1 medications in children with obesity, and what personalized treatment means for the future.

Today’s post carries on from “The Nutrition That Never Arrived,” which discusses the work of Dr. Dhruv Khullar, as well as a study of ultra-processed foods.

Learn how GLP-1 medications are transforming childhood obesity treatment, including benefits, risks, and access challenges for families.

A ton of money was being spent to repair the ravages of BPA on kids, and on young people and adults who had encountered it in early life.

Childhood obesity may limit future income and mobility. Learn how early health impacts education, careers, and the American Dream.

Check out that headline: “Why Is the American Diet So Deadly?” The adjective isn’t “detrimental” or even “dangerous,” but a much more loaded d-word: deadly.

New research shows reducing parent stress may help prevent childhood obesity. Learn how mindfulness and positive parenting support healthier kids.

As society operates today, high weight status coexists with low societal status and low economic status, and quite often with racial minority status.

CDC data show 21.1% of U.S. children have obesity — a record high. Experts warn of rising risks and call for urgent prevention and treatment efforts.

Caregivers’ trust, values, and food insecurity shape decisions about GLP-1 medications for children with obesity, highlighting need for shared decision-making.

FDA approves the first Wegovy weight loss pill, offering an oral GLP-1 alternative with results similar to injections.

New research reveals how gut microbes send metabolites to the liver and heart, shaping insulin sensitivity and metabolism linked to obesity and type 2 diabetes.